Cassidy Blundell

Director/Board Member at Arase Therapeutics, Inc.

Consumer Services

Health Technology

Finance

Profile

Cassidy Blundell is currently working as a Principal at BioInnovation Management LLC and is also a Board Member at Arase Therapeutics, Inc. She holds a doctorate degree from the University of Pennsylvania, which she received in 2018, and a graduate degree from Boston University, which she received in 2012.

Cassidy Blundell active positions

Companies	Position	Start
Arase Therapeutics, Inc. Arase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arase Therapeutics, Inc. is a science-focused oncology company located in Cambridge, MA. The company is developing first-in-class therapeutics targeting adp-ribose hydrolases, novel targets that function therapeutically. The company's leadership includes scientists and founders Paul Chang, Ph.D., W. Lee Kraus, Ph.D., and Michael Taylor, Ph.D. The company's mission is supported by Biocapital, a founding investor, and the board is led by Paul Chang, Ph.D., who serves as the President, CEO/CSO, and lead founder. Cassidy Blundell, Ph.D., a principal at Mission Biocapital, and W. Lee Kraus, Ph.D., a scientific founder, also serve on the board.	Director/Board Member	-
BioInnovation Management LLC BioInnovation Management LLC Investment ManagersFinance BioInnovation Management LLC (Bioinnovation Management) is a venture capital firm founded in 2009 by Peter D Parker and Susie T Harborth. The firm is headquartered in Cambridge, Massachusetts.	Private Equity Investor	31/08/2021

All active positions of Cassidy Blundell

Training of Cassidy Blundell

University of Pennsylvania	Doctorate Degree
Boston University	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Cassidy Blundell's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Arase Therapeutics, Inc. Arase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arase Therapeutics, Inc. is a science-focused oncology company located in Cambridge, MA. The company is developing first-in-class therapeutics targeting adp-ribose hydrolases, novel targets that function therapeutically. The company's leadership includes scientists and founders Paul Chang, Ph.D., W. Lee Kraus, Ph.D., and Michael Taylor, Ph.D. The company's mission is supported by Biocapital, a founding investor, and the board is led by Paul Chang, Ph.D., who serves as the President, CEO/CSO, and lead founder. Cassidy Blundell, Ph.D., a principal at Mission Biocapital, and W. Lee Kraus, Ph.D., a scientific founder, also serve on the board.	Health Technology
BioInnovation Management LLC BioInnovation Management LLC Investment ManagersFinance BioInnovation Management LLC (Bioinnovation Management) is a venture capital firm founded in 2009 by Peter D Parker and Susie T Harborth. The firm is headquartered in Cambridge, Massachusetts.	Finance